[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349421-105":59,"doc-detail-349421-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-comparison-of-cancer-treatment-protocols-in-australia-canada-and-the-united-kingdom","A comparison of cancer treatment protocols in Australia, Canada, and the United Kingdom","","National cancer treatment protocols shape drug selection, dosing, and patient access. Although Australia, Canada, and the United Kingdom (UK) use similar socialised healthcare models, alignment across their treatment protocols is not well established. This study cross-sectionally compared in-use protocols (as of January 2025) from eviQ, Cancer Care Ontario, and the Clatterbridge Cancer Centre, focusing on chemotherapy drug inclusion, cancer-specific indications, and dosing recommendations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-comparison-of-cancer-treatment-protocols-in-australia-canada-and-the-united-kingdom/349421/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-comparison-of-cancer-treatment-protocols-in-australia-canada-and-the-united-kingdom/349421.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main goal?","Question",{"text":112,"@type":113},"To compare how Australia, Canada, and the UK incorporate chemotherapy drugs into national cancer treatment protocols, including drug selection, cancer indications, and dosing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which protocol sources were analyzed?",{"text":117,"@type":113},"Protocols in use as of January 2025 from eviQ (Australia), Cancer Care Ontario (Canada), and the Clatterbridge Cancer Centre (UK) were reviewed.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about overlap in chemotherapy drug use?",{"text":121,"@type":113},"Among 243 chemotherapy drugs across 2,450 protocols, 51% were used in all three countries, while 72% appeared in at least two, with the greatest overlap for commonly used cytotoxic agents in high-incidence cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349421,1790450403,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Lee et al. BMC Cancer (2026) 26:816 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16139-3](https://doi.org/10.1186/s12885-026-16139-3)  \nRESEARCH Open Access  \nA comparison of cancer treatment protocols in Australia, Canada, and the United Kingdom  \nJasmine Lee1, Anastasios Panagiotelis2, Rose Cairns1,3 and Nial J. Wheate4*  \nAbstract  \nBackground National cancer treatment protocols guide drug selection, dosing, and access to care. While Australia, Canada, and the United Kingdom (UK) have similar socialised healthcare systems, the extent to which their treatment protocols align remains unclear. This study compared protocols across these countries, examining drug selection, distribution by cancer type, and dosing.  \nMethods A cross-sectional analysis was conducted of in-use protocols as of January 2025 from eviQ (Australia), Cancer Care Ontario (Canada), and the Clatterbridge Cancer Centre (UK). Protocols were reviewed to identify and compare chemotherapy drugs, their cancer indications, and recommended doses.  \nResults Among 243 chemotherapy drugs across 2,450 protocols, 51%(123/243) were used in all three countries and 72%(175/243) appeared in at least two. Overlap was greatest for commonly used cytotoxic agents in high-incidence cancers. Dosing practices varied: Canadian protocols often recommended higher median doses, UK protocols used narrower minimum dose ranges, and Australian protocols demonstrated wider minimum–maximum dose ranges across several drugs.  \nConclusions Despite comparable access to internationally available therapies, treatment approaches vary across Australia, Canada, and the UK. As countries that frequently participate in multinational clinical trials and operate within similar evidence-based guideline and appraisal systems, these differences highlight opportunities for greater alignment. Cross-country comparisons may support collaborative efforts in protocol development and data sharing to standardise care, particularly for rare and emerging therapies targeting smaller patient populations.  \nKeywords Cancer, Comparison, Treatment, Protocols, Drugs, Australia, Canada, United Kingdom  \n*Correspondence:  \nNial J. Wheate  \n[nial.wheate@mq.edu.au](nial.wheate@mq.edu.au)  \n1School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia  \n2Monash Business School, Monash University, Melbourne, VIC, Australia 3New South Wales Poisons Information Centre, The Children’s Hospital at Westmead, Sydney, NSW, Australia  \n4School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, Australia  \nIntroduction  \nThe range of available cancer therapies has expanded rapidly in recent decades, yet differences remain in how these drugs are incorporated into national treatment protocols. Variation in drug selection and dosing across comparable healthcare systems may affect consistency of care and highlights the need for cross-country comparisons to support greater alignment in evidence-based practice [1–3].  \nAustralia, Canada, and the United Kingdom (UK) are comparable high-income countries with universal or publicly funded (socialised) healthcare systems  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intend","cbCait2l78KPIvWo","https://ap.wps.com/l/cbCait2l78KPIvWo","pdf",1367885,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What was the study’s main goal?\",\"answer\":\"To compare how Australia, Canada, and the UK incorporate chemotherapy drugs into national cancer treatment protocols, including drug selection, cancer indications, and dosing.\"},{\"question\":\"Which protocol sources were analyzed?\",\"answer\":\"Protocols in use as of January 2025 from eviQ (Australia), Cancer Care Ontario (Canada), and the Clatterbridge Cancer Centre (UK) were reviewed.\"},{\"question\":\"What did the study find about overlap in chemotherapy drug use?\",\"answer\":\"Among 243 chemotherapy drugs across 2,450 protocols, 51% were used in all three countries, while 72% appeared in at least two, with the greatest overlap for commonly used cytotoxic agents in high-incidence cancers.\"}]","A comparison of cancer treatment protocols in Australia, Canada, and the United Kingdom | PDF",1790083240,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f4c394d2371070049612c0e8be7754a.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97282c6780d87eafbee41c2a4b7c2e76.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1c237fc8f6b77b5aa24890989495669.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1b503ddff6996232cc049b8953bc3ae.webp",980,1306]